Antibody-negative neuromyelitis optica with heavy B-cell infiltration

APMIS

Volumn 117, Issue 10, 2009, Pages 768-772

  Blackburn, Daniel ^a   Highley, John Robin ^b   Wharton, Steve ^b   Romanowski, Charles ^a   Bowen, John ^a   Sharrack, Basil ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

B lymphocytes; Neuromyelitis optica

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MITOXANTRONE;

ADULT; ANAMNESIS; ARTICLE; B LYMPHOCYTE; BRAIN ANGIOGRAPHY; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EVOKED VISUAL RESPONSE; HUMAN; MALE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIBODIES; B-LYMPHOCYTES; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROMYELITIS OPTICA; SPINAL CORD;

EID: 70349317474     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02525.x     Document Type: Article

References (15)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 364 : 2106 2112. (Pubitemid 39626806)
2. Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007 68 : 1076 1077.
3. Klawiter EC, Alvarez 3rd. E, Xu J, Paciorkowski AR, Zhu L, Parks BJ, et al. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology 2009 72 : 1101 1103.
4. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006 59 : 566 569.
5. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999 53 : 1107 1114.
6. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006 63 : 390 396.
7. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004 251 : 47 52. (Pubitemid 38210489)
8. Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y. An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler 2005 11 : 735 738.
9. Lucchinetti CF. Update on the international project on pathologic correlates in MS. Mult Scler 2005 11 : 99 100.
10. Prineas JW, MWaFR. Demyelinating diseases. In : Neuropathology, 7th edn. London : Arnold, 2002 : 471 550.
11. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002 125 : 1450 1461.
12. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007 130 : 1089 1104.
13. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005 64 : 1270 1272.
14. Capobianco M, Malucchi S, di Sapio A, Gilli F, Sala A, Bottero R, et al. Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). Neurol Sci 2007 28 : 209 211.
15. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 2008 358 : 676 688.